The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
E. Jenny Heathcote, Karen Cauch‐Dudek, Valery Walker, Robert J. Bailey, Laurence M. Blendis, Cameron N. Ghent, Pina Michieletti, Gerald Y. Minuk, S. Chris Pappas, Linda J. Scully, Urs P. Steinbrecher, Lloyd R. Sutherland, C. Noel Williams, Helga Witt‐Sullivan, Lawrence J. Worobetz, Ruth A. Milner, Ian R. Wanless – 1 May 1994 – Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile acids are retained in the liver and are hepatotoxic.